AMSEL MEDICAL CORPORATION — Federal Contracts, Awards & Government Contractor Profile

About AMSEL MEDICAL CORPORATION

Amsel Medical Corporation is a pre-commercialization stage medical device company founded in 2011 in Cambridge, MA, specializing in the development of the SCureClamp™ with Interdigitation Occlusion Technology (iDOT™) for secure vessel occlusion during surgical and interventional procedures.

Development and delivery of SCureClamp™ with iDOT™ for secure vessel occlusionMinimally invasive 18 G needle delivery for clamping of blood vessels, ducts, arteries, and veinsFDA and CE mark cleared for use in open general surgery and laparoscopic proceduresPermanent non-chemical, non-thermal, non-tumescent, and non-compression occlusionUltrasound guided targeting for percutaneous and laparoscopic applications

Recent Federal Awards

Award	Agency	Amount
RAPID SITE SPECIFIC NEEDLE DELIVERY ADJUSTABLE VESSEL OCCLUSION FOR CONTROL OF JUNCTIONAL AND NON-COMPRESSIBLE	Department of Defense	$1.5M
Federal contract award	Department of Defense	$59K
NON-SURGICAL CONTROL OF JUNCTIONAL AND NON-COMPRESSIBLE HEMORRHAGE VIA PERCUTANEOUSLY DELIVERED ADJUSTABLE VES	Department of Defense	$5.5M
Federal contract award	Department of Defense	$1000K

Is this your company?

Claim AMSEL MEDICAL CORPORATION to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.

Claim AMSEL MEDICAL CORPORATION & see your matches

Free to claim. Takes about a minute.

Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.